ResultsIQ

ResultsIQ › Latest results › Oriental Aromatics Limited

Oriental Aromatics Limited Q4 FY26 earnings call summary

NSE: OAL · BSE: 500078

Earnings call of 21 May 2026, summarised by AI from the filing.

Oriental Aromatics crossed ₹1,000 cr FY26 revenue at ₹1,030 cr, but EBITDA margin fell to 6.6% and management targets around 10% in FY27.

Key takeaways

  1. FY26 revenue Consolidated revenue from operations crossed ₹1,000 cr for the first time at ₹1,030 cr (FY25: ₹928 cr, 11% growth).
  2. Margin guidance Management will endeavor to return to the guided EBITDA margin of around 10% in FY27.
  3. Margin compression FY26 EBITDA margin fell to 6.6% from 10.06% in FY25 on pricing pressure, raw material inflation, currency depreciation and Mahad drag.
  4. Volume growth FY26 sales volume grew 9% and production volume 5% over FY25 despite pricing and demand pressure.
  5. Input costs Gum turpentine, CST and alpha-pinene prices are at all-time highs and the situation may worsen before normalcy returns.

Original filing on BSE

Oriental Aromatics Limited Q1 FY27 results

As filed: Revenue ₹260 cr (+15% year on year), EBITDA ₹19.8 cr (+4% year on year), PAT ₹2.5 cr (+151% year on year), EBITDA margin 7.6% (−79 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹282 cr (+12% year on year), EBITDA ₹19.5 cr (−3% year on year), PAT ₹4.0 cr (+299% year on year), EBITDA margin 6.9% (−101 bps). Score 41 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA growth was below it; profit growth was well above it. EBITDA margin fell 101 bps year on year. Other income 58% of PBT. Tax rate 46%. Share price after the results: +11.6% in 30 days (Nifty 500: +2.5%).
  • Q3 FY26: Revenue ₹252 cr (+13% year on year), EBITDA ₹13.2 cr (−40% year on year), PAT −₹1.9 cr (−127% year on year), EBITDA margin 5.3% (−461 bps). Score 20 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA growth was below it; profit growth was well below it. EBITDA margin fell 461 bps year on year. Revenue fell 7% from last quarter. Share price after the results: −23.9% in 29 days (Nifty 500: −9.6%).
  • Q2 FY26: Revenue ₹271 cr (+14% year on year), EBITDA ₹18.0 cr (−36% year on year), PAT ₹1.0 cr (−93% year on year), EBITDA margin 6.6% (−517 bps). Score 28 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA growth was well below it; profit growth was below it. EBITDA margin fell 517 bps year on year. Other income 100% of PBT. Tax rate 67%. Share price after the results: −14.8% in 30 days (Nifty 500: −0.8%).
  • Q1 FY26: Revenue ₹226 cr (+5% year on year), EBITDA ₹19.0 cr (−14% year on year), PAT ₹1.0 cr (−91% year on year), EBITDA margin 8.4% (−178 bps). Score 23 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 178 bps year on year. Tax rate 67%. Revenue fell 11% from last quarter. Share price after the results: −3.5% in 28 days (Nifty 500: +1.7%).
  • Q4 FY25: Revenue ₹253 cr (+17% year on year), EBITDA ₹20.0 cr (0% year on year), PAT ₹1.0 cr (−90% year on year), EBITDA margin 7.9% (−135 bps). Score 38 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 135 bps year on year. Tax rate 50%. Profit fell 86% from last quarter. Share price after the results: −8.9% in 30 days (Nifty 500: +3.1%).
  • Q3 FY25: Revenue ₹223 cr (+13% year on year), EBITDA ₹22.0 cr (+57% year on year), PAT ₹7.0 cr (+133% year on year), EBITDA margin 9.9% (+276 bps). Score 54 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was below it. EBITDA margin rose 276 bps year on year. Revenue fell 6% from last quarter.
  • Q2 FY25: Revenue ₹237 cr (+4% year on year), EBITDA ₹28.0 cr (+180% year on year), PAT ₹15.0 cr (+300% year on year), EBITDA margin 11.8% (+741 bps). Score 78 of 100, Above trend. EBITDA margin rose 741 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Oriental Aromatics Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.